Timed Bromocriptine-QR Therapy Reduces Progression of Cardiovascular Disease and Dysglycemia in Subjects with Well-Controlled Type 2 Diabetes Mellitus von Cincotta, A. H., Ezrokhi, Michael, Scranton, Richard E., Vinik, Aaron I., Blonde, Lawrence, Gaziano, J. Michael, Chamarthi, Bindu, Rutty, Dean

Volltext

A Phase III, Randomized, Multi-Center, Open-Label, Fixed Dose, Neulasta Active-Controlled Clinical Trial of F-627, a Novel G-CSF, in Women with Breast Cancer Receiving Myelotoxic C... von Glaspy, John, Daley, William, Bondarenko, Igor, Rutty, Dean, Chen, Jianmin

Volltext

Efbemalenograstim alfa not inferior to pegfilgrastim in providing neutrophil support in women with breast cancer undergoing myelotoxic chemotherapy: results of a phase 2 randomized... von Glaspy, John, Bondarenko, Igor, Krasnozhon, Dmitrii, Rutty, Dean, Chen, Jianmin, Fu, Yanyan, Wang, Shufang, Hou, Qingsong, Li, Simon

Volltext

Efbemalenograstim alfa, an Fc fusion protein, long-acting granulocyte-colony stimulating factor for reducing the risk of febrile neutropenia following chemotherapy: results of a ph... von Glaspy, John, Bondarenko, Igor, Burdaeva, Olga, Chen, Jianmin, Rutty, Dean, Li, Renshu, Wang, Shufang, Hou, Qingsong, Li, Simon

Volltext

A randomized, double-blind, placebo-controlled trial to assess safety and tolerability during treatment of type 2 diabetes with usual diabetes therapy and either Cycloset or placeb... von Scranton, Richard E, Gaziano, J Michael, Rutty, Dean, Ezrokhi, Michael, Cincotta, Anthony

Volltext

Randomized Clinical Trial of Quick-Release Bromocriptine Among Patients With Type 2 Diabetes on Overall Safety and Cardiovascular Outcomes von Gaziano, J. Michael, Cincotta, Anthony H, O'Connor, Christopher M, Ezrokhi, Michael, Rutty, Dean, Ma, Z.J, Scranton, Richard E

Volltext

A Phase II, Randomized, Multi-Centre, Open-Label, Active-Controlled, Dose-Finding Trial of F-627 (benefilgrastim) in Women with Breast Cancer Receiving Myelotoxic Chemotherapy von Glaspy, John, Tang, Tom, Rutty, Dean, Yan, Xiaoqiang, Bondarenko, Igor, Krasnozhon, Dmitrii

Volltext

Erratum. Randomized Clinical Trial of Quick-Release Bromocriptine Among Patients With Type 2 Diabetes on Overall Safety and Cardiovascular Outcomes von Gaziano, J Michael, Cincotta, Anthony H, O'Connor, Christopher M, Ezrokhi, Michael, Rutty, Dean, Ma, Z J, Scranton, Richard E

Volltext

Timed Bromocriptine-QR Therapy Reduces Progression of Cardiovascular Disease and Dysglycemia in Subjects with Well-Controlled Type 2 Diabetes Mellitus von Chamarthi, Bindu, Gaziano, J. Michael, Blonde, Lawrence, Vinik, Aaron, Scranton, Richard E, Ezrokhi, Michael, Rutty, Dean, Cincotta, Anthony H

Volltext

A Randomized, Double-Blind, Placebo-Controlled Trial to Assess Safety and Tolerability During Treatment of Type 2 Diabetes with Usual Diabetes Therapy and Either Cycloset™ or Place... von Scranton, Richard E, Gaziano, John Michael, Rutty, Dean, Ezrokhi, Michael, Cincotta, Anthony

Volltext